11 investors predict a colorful, if difficult, future for psychedelic startups
TechCrunch
MAY 12, 2023
Whether developing a drug or not, a company would be attractive to investors if and only if it is addressing a key problem in the market that cannot already be solved by incumbents efficiently. What is riskier, especially at this point in time, are pure drug discovery companies that don’t have any leads to take into trials anytime soon.
99 
Let's personalize your content